RePACE H 50 mg+12.5 mg (Tablet)
Unit Price: ৳ 8.03 (5 x 10: ৳ 401.50)
Strip Price: ৳ 80.30
Medicine Details
| Category | Details |
|---|---|
| Generic | Losartan potassium hydrochlorothiazide |
| Company | Sun pharmaceutical bangladesh ltd |
Product Title
- RePACE H Tablet
Categories
- Hypertension Medication
- Antihypertensive Drug
Description
- RePACE H is used for the treatment of hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy. It is a combined antihypertensive preparation containing Losartan and Hydrochlorothiazide.
Dosage Instructions
- The usual starting dose of the 50/12.5 combination is one tablet once daily. For severe hypertension, the starting dose is one tablet of 50/12.5 once daily. The dosage may be increased based on patient response.
Administration Options
- May be administered with or without food
Interaction Warnings
- May interact with potassium-sparing diuretics, non-steroidal anti-inflammatory drugs, alcohol, barbiturates, narcotics, antidiabetic drugs, other antihypertensive drugs, and certain resins.
Contraindications
- Hypersensitivity to any component of the product, anuria, or hypersensitivity to sulfonamide-derived drugs
Side Effects
- Symptomatic hypotension, dizziness, hyperkalemia, angioedema, vertigo, gastrointestinal disturbances, angina, palpitation, edema, dyspnea, headache, sleep disorders, malaise, urticaria, pruritus, rash, hepatitis, atrial fibrillation, cerebrovascular accident, syncope, pancreatitis, anaphylaxis, cough, depression, erectile dysfunction, anemia, thrombocytopenia, hyponatremia, arthralgia, myalgia, renal impairment, rhabdomyolysis, tinnitus, photosensitivity, vasculitis
Pregnancy & Lactation Precautions
- Avoid use in pregnancy unless essential, not recommended during breastfeeding
Precautions & Warnings
- Hypersensitivity precautions, periodic serum electrolyte determination, risk of hypokalemia, impaired renal function, and symptomatic hypotension
Special Population Usage
- Use in Patients with Renal Impairment: Usual regimens may be followed if creatinine clearance is >30 ml/min. Loop diuretics are preferred in more severe renal impairment.
- Use in Patients with Hepatic Impairment: Not recommended for titration in patients with hepatic impairment
- Use in pediatric patients: Safety and effectiveness not established
Overdose Effects
- Manifestation of overdosage may include hypotension, tachycardia, bradycardia, electrolyte depletion, dehydration. Supportive treatment should be instituted.
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C. Keep out of the reach of children.